To enrich CSCs, cells were cultured in DMEM/F12 medium without FBS, and supplemented with 100 μg/mL streptomycin and 100 units/mL penicillin, 20 ng/ml human recombinant epidermal growth factor (EGF), 20 ng/ml human recombinant basic fibroblast growth factor (bFGF), and 2% B27 supplement (Invitrogen, USA) and seeded in 6-well cell culture plate with ultra-low attachment surface (BioFLOAT, USA). Medium was half-refreshed every three days.
To evaluate the effects of Fumagillin on cell viability, 1, 2.5, 5, 7.5 and 10 μmol/L of Fumagillin, bought from Sigma-Aldrich (USA) in stock at final concentration of 20 mmol/L, was added for 24-hour incubation. To evaluate the effects of Fumagillin on sphere formation, Fumagillin was added for 24–96 h. To evaluate the effects of Fumagillin in maintenance of stemness, Fumagillin was added into spheres.